Table of Contents
Chapter 1. Global Cell Therapy Biomanufacturing Market Executive Summary
1.1. Global Cell Therapy Biomanufacturing Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Cell Type
1.3.3. By Process
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Cell Therapy Biomanufacturing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Cell Therapy Biomanufacturing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Chronic Diseases
3.1.2. Advancements in Biotechnology
3.1.3. Government and Private Sector Investments
3.2. Market Challenges
3.2.1. High Manufacturing Costs
3.3. Market Opportunities
3.3.1. Personalized Medicine
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Cell Therapy Biomanufacturing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Product Type 2024-2032
5.1. Segment Dashboard
5.2. Global Cell Therapy Biomanufacturing Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Consumables
5.2.2. Equipment
5.2.3. Systems & Software
Chapter 6. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Cell Type 2024-2032
6.1. Segment Dashboard
6.2. Global Cell Therapy Biomanufacturing Market: Cell Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. T-cell
6.2.2. Stem Cell
6.2.3. Other Cell
Chapter 7. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Process 2024-2032
7.1. Segment Dashboard
7.2. Global Cell Therapy Biomanufacturing Market: Process Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Cell Processing
7.2.2. Cell Preservation, Distribution, and Handling
7.2.3. Process Monitoring and Quality Control
Chapter 8. Global Cell Therapy Biomanufacturing Market Size & Forecasts by End User 2024-2032
8.1. Segment Dashboard
8.2. Global Cell Therapy Biomanufacturing Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Biopharmaceutical & Biotechnology Companies and CROs
8.2.2. Research Institutes and Cell Banks
Chapter 9. Global Cell Therapy Biomanufacturing Market Size & Forecasts by Region 2024-2032
9.1. North America Cell Therapy Biomanufacturing Market
9.1.1. U.S. Cell Therapy Biomanufacturing Market
9.1.1.1. Product Type breakdown size & forecasts, 2024-2032
9.1.1.2. Cell Type breakdown size & forecasts, 2024-2032
9.1.1.3. Process breakdown size & forecasts, 2024-2032
9.1.1.4. End User breakdown size & forecasts, 2024-2032
9.1.2. Canada Cell Therapy Biomanufacturing Market
9.2. Europe Cell Therapy Biomanufacturing Market
9.2.1. U.K. Cell Therapy Biomanufacturing Market
9.2.2. Germany Cell Therapy Biomanufacturing Market
9.2.3. France Cell Therapy Biomanufacturing Market
9.2.4. Spain Cell Therapy Biomanufacturing Market
9.2.5. Italy Cell Therapy Biomanufacturing Market
9.2.6. Rest of Europe Cell Therapy Biomanufacturing Market
9.3. Asia-Pacific Cell Therapy Biomanufacturing Market
9.3.1. China Cell Therapy Biomanufacturing Market
9.3.2. India Cell Therapy Biomanufacturing Market
9.3.3. Japan Cell Therapy Biomanufacturing Market
9.3.4. Australia Cell Therapy Biomanufacturing Market
9.3.5. South Korea Cell Therapy Biomanufacturing Market
9.3.6. Rest of Asia Pacific Cell Therapy Biomanufacturing Market
9.4. Latin America Cell Therapy Biomanufacturing Market
9.4.1. Brazil Cell Therapy Biomanufacturing Market
9.4.2. Mexico Cell Therapy Biomanufacturing Market
9.4.3. Rest of Latin America Cell Therapy Biomanufacturing Market
9.5. Middle East & Africa Cell Therapy Biomanufacturing Market
9.5.1. Saudi Arabia Cell Therapy Biomanufacturing Market
9.5.2. South Africa Cell Therapy Biomanufacturing Market
9.5.3. Rest of Middle East & Africa Cell Therapy Biomanufacturing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. MaxCyte (US)
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Thermo Fisher Scientific Inc. (US)
10.3.3. L7 Informatics, Inc. (US)
10.3.4. MAK-SYSTEM (US)
10.3.5. SIRION Biotech GmbH (Germany)
10.3.6. Fresenius Medical Care AG & Co. KGaA (Germany)
10.3.7. Sartorius AG (Germany)
10.3.8. STEMCELL Technologies (Canada)
10.3.9. Werum IT Solutions GmbH (Germany)
10.3.10. Terumo BCT (US)
10.3.11. Corning Incorporated (US)
10.3.12. OrganaBio, LLC (US)
10.3.13. Merck KGaA (Germany)
10.3.14. Becton, Dickinson and Company (US)
10.3.15. Miltenyi Biotec GmbH (Germany)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes